A 99mTc-labeled gemcitabine bisphosphonate drug conjugate as a probe to assess the potential for targeted chemotherapy of metastatic bone cancer-Reference-Cited by-同舟云学术

A 99mTc-labeled gemcitabine bisphosphonate drug conjugate as a probe to assess the potential for targeted chemotherapy of metastatic bone cancer

Published:2006-08 Issue:6 Volume:33 Page:715-722
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

El-Mabhouh Amal A.,Angelov Christo A.,Cavell Ron,Mercer John R.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference26 articles.

1. Canadian Cancer Society/National Cancer Institute of Canada: Canadian Cancer Statistics 2005, Toronto, Canada, 2005. http://www.cancer.ca/vgn/images/portal/cit_86751114/48/28/401594768cw_2005stats_en.pdf.

2. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC CancerBase No. 5;Ferlay,2001

3. Metastatic bone disease: clinical features, pathophysiology and treatment strategies;Coleman;Cancer Treat Rev,2001

4. High-dose chemotherapy in breast cancer;Lake;Drugs,2004

5. Bisphosphonates: mechanisms of action;Fleisch;Endocrinol Rev,1998

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering small-molecule and protein drugs for targeting bone tumors;Molecular Therapy;2024-05

2. Radiolabeled chemotherapeutics as a novel strategy for targeted cancer therapy: current insights and future perspectives;Journal of Radioanalytical and Nuclear Chemistry;2023-12-07

3. Bisphosphonate-Based Conjugates and Derivatives as Potential Therapeutic Agents in Osteoporosis, Bone Cancer and Metastatic Bone Cancer;International Journal of Molecular Sciences;2021-06-26

4. “The use of bisphosphonates to treat skeletal complications in solid tumours”;Bone;2021-06

5. Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overview;Journal of the Egyptian National Cancer Institute;2021-02-08